Kenyataan Media Pengarah NPRA 16 Mac 2022 - Status Laporan Kesan Advers Susulan Imunisasi (AEFI) Vaksin COVID-19 Sehingga 11 Mac 2022
- Posted By Amir Imran Abdul Rahaman
- Hits: 20577
User Rating: 5 / 5
 |
 |
 |
 |
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
- Email: npra@npra.gov.my
- Phone: +603-7883 5400
- Fax: +603-7956 2924, +603-7956 7075
 |
 |
 |
 |
More Links
DISCLAIMER
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Mobile Web :
Site Last Modified
- Last Modified: Wednesday 07 June 2023, 15:28:06.